Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Evofem Biosciences, Inc. | evfm-12312020ex32110k.htm |
| EX-31.2 - EX-31.2 - Evofem Biosciences, Inc. | evfm-12312020ex31210k.htm |
| EX-31.1 - EX-31.1 - Evofem Biosciences, Inc. | evfm-12312020ex31110k.htm |
| EX-21.1 - EX-21.1 - Evofem Biosciences, Inc. | evfm-12312020ex211listofre.htm |
| EX-10.31 - EX-10.31 - Evofem Biosciences, Inc. | evfm-12312020ex1031nonxemp.htm |
| EX-10.30 - EX-10.30 - Evofem Biosciences, Inc. | evfmexhibit1030.htm |
| EX-10.27 - EX-10.27 - Evofem Biosciences, Inc. | evfm-12312020ex1027amended.htm |
| EX-10.16 - EX-10.16 - Evofem Biosciences, Inc. | evfm-12312020ex1016evofemb.htm |
| EX-4.17 - EX-4.17 - Evofem Biosciences, Inc. | evfm-fy2010xkex417descript.htm |
| 10-K - 10-K - Evofem Biosciences, Inc. | evfm-20201231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-234769, 333-232303, 333-231126, 333-230191, and 333-223731 on Form S-3 and Registration Statement Nos. 333-252516, 333-238228, 333-237126, 333-237119, 333-231993, 333-231991, 333-226517 and 333-225366 on Form S-8 of our report dated March 4, 2021, relating to the financial statements of Evofem Biosciences, Inc. appearing in this Annual Report on Form 10-K for the year ended December 31, 2020.
/s/ DELOITTE & TOUCHE LLP
San Diego, California
March 4, 2021
1